The IGLoS signature also demonstrated significant differences between tumor and normal tissues in pan‐cancer, among which the expression of CCL19 was lower in most tumors, while the other five genes showed higher expression in most tumors (Figure S2D, Supporting Information). The gene discussed is CCL19; the disease is neoplasm.